{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:05:26Z","timestamp":1791230726516,"version":"4.1.0"},"reference-count":166,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Melatonin (N-acetyl-5-methoxytryptamine, MLT), the main hormone produced by the pineal gland, not only regulates circadian rhythm, but also has antioxidant,  anti-ageing and immunomodulatory properties. MLT plays an important role in blood composition, medullary dynamics, platelet genesis, vessel endothelia, and in platelet aggregation, leukocyte formula regulation and hemoglobin synthesis. Its significant atoxic, apoptotic, oncostatic, angiogenetic, differentiating and antiproliferative properties against all solid and liquid tumors have also been documented. Thanks, in fact, to its considerable functional versatility, MLT can exert both direct and indirect anticancer effects in factorial synergy with other differentiating, antiproliferative, immunomodulating and trophic molecules that form part of the anticancer treatment formulated by Luigi Di Bella (Di Bella Method, DBM: somatostatin, retinoids, ascorbic acid, vitamin D3, prolactin inhibitors, chondroitin-sulfate). The interaction between MLT and the DBM molecules counters the multiple processes that characterize the neoplastic phenotype (induction, promotion, progression and\/or dissemination, tumoral mutation). All these particular characteristics suggest the use of MLT in oncological diseases.<\/jats:p>","DOI":"10.3390\/ijms14022410","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T11:29:13Z","timestamp":1359026953000},"page":"2410-2430","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":145,"title":["Melatonin Anticancer Effects: Review"],"prefix":"10.3390","volume":"14","author":[{"given":"Giuseppe","family":"Di Bella","sequence":"first","affiliation":[{"name":"Di Bella Foundation, Via Guglielmo Marconi 51, Bologna 40122, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Mascia","sequence":"additional","affiliation":[{"name":"Di Bella Foundation, Via Guglielmo Marconi 51, Bologna 40122, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Gualano","sequence":"additional","affiliation":[{"name":"Private Laboratory of Physiology, Via Stefano Giovanni Marianini, Modena 41123, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Di Bella","sequence":"additional","affiliation":[{"name":"Private Laboratory of Physiology, Via Stefano Giovanni Marianini, Modena 41123, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yfrne.2004.08.001","article-title":"Human pineal physiology and functional significance of melatonin","volume":"25","author":"Macchi","year":"2004","journal-title":"Front. Neuroendocrinol"},{"key":"ref_2","first-page":"61","article-title":"Melatonin in immunity: Comparative aspects","volume":"2","year":"2002","journal-title":"Neuro Endocrinol. Lett"},{"key":"ref_3","first-page":"1537","article-title":"Clinical aspects of melatonin","volume":"29","author":"Reiter","year":"2008","journal-title":"Saudi Med. J"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1600-079X.2009.00731.x","article-title":"The protective effect of melatonin on methamphetamine-induced calpain-dependent death pathway in human neuroblastoma SH-SY5Y cultured cells","volume":"48","author":"Suwanjang","year":"2010","journal-title":"J. Pineal Res"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Proietti, S., Cucina, A., Reiter, R.J., and Bizzarri, M (2012). Molecular mechanisms of melatonin\u2019s inhibitory actions on breast cancers. Cell. Mol. Life Sci.","DOI":"10.1007\/s00018-012-1161-8"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rodriguez-Garcia, A., Mayo, J.C., Hevia, D., Quiros-Gonzalez, I., Navarro, M., and Sainz, R.M. (2012). Phenotypicchanges caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis. J. Pineal Res.","DOI":"10.1111\/j.1600-079X.2012.01017.x"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s11033-011-1043-4","article-title":"Induction of cell differentiation and promotion of endocan gene expression in stomach cancer bymelatonin","volume":"39","author":"Zhang","year":"2012","journal-title":"Mol. Biol. Rep"},{"key":"ref_8","first-page":"481","article-title":"Effect of melatonin on the functional properties of transformed cells","volume":"57","author":"Kirpichnikova","year":"2011","journal-title":"Vopr. Onkol"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1568026023394407","article-title":"Melatonin as a chronobiotic\/anticancer agent: Cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy","volume":"2","author":"Blask","year":"2002","journal-title":"Curr. Top Med Chem"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2004.00207.x","article-title":"Melatonin-estrogen interactions in breast cancer","volume":"38","author":"Cos","year":"2005","journal-title":"J. Pineal Res"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1016\/S0024-3205(00)00882-1","article-title":"Effect of melatonin and pineal extracts on human ovarian and mammary tumor cells in a chemosensitivity assay","volume":"67","author":"Bartsch","year":"2000","journal-title":"Life Sci"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1447-0756.2008.00818.x","article-title":"Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line","volume":"34","author":"Watanabe","year":"2008","journal-title":"J. Obstet. Gynaecol. Res"},{"key":"ref_13","first-page":"109","article-title":"Platelet-derived growth factor and autocrine mechanisms of oncogenic processes","volume":"2","author":"Heldin","year":"1991","journal-title":"Crit. Rev. Oncog"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/01.HYP.19.2.117","article-title":"Endothelium-derived contracting factors","volume":"19","author":"Boulanger","year":"1992","journal-title":"Hypertension"},{"key":"ref_15","first-page":"131","article-title":"Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells","volume":"65","author":"Comoglio","year":"1993","journal-title":"EXS"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-079X.1994.tb00110.x","article-title":"Melatonin modulates growth factor activity in MCF-7 human breast cancer cells","volume":"17","author":"Cos","year":"1994","journal-title":"J. Pineal Res"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/cbir.1995.1086","article-title":"The epidermal growth factor","volume":"19","author":"Boonstra","year":"1995","journal-title":"Cell Biol. Int"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","volume":"2","author":"Ornitz","year":"2001","journal-title":"Genome Biol"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000046610","article-title":"The role of vascular endothelial growth factor in angiogenesis","volume":"106","author":"Ferrara","year":"2002","journal-title":"Acta Haematol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00109-003-0499-7","article-title":"Role of insulin-like growth factor I signaling in neurodegenerative diseases","volume":"82","author":"Trejo","year":"2004","journal-title":"J. Mol. Med"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.108.841981","article-title":"Circulating transforming growth factor-\u03b2 in Marfan syndrome","volume":"120","author":"Matt","year":"2009","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-079X.2007.00542.x","article-title":"Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3\/ casp-7) and PARP in UVR-exposed HaCaT keratinocytes","volume":"44","author":"Fischer","year":"2008","journal-title":"J. Pineal Res"},{"key":"ref_23","first-page":"715","article-title":"Melatonin: Cell death modulator","volume":"56","author":"Maganhin","year":"2010","journal-title":"Rev. Assoc. Med. Bras"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.2174\/092986712801661013","article-title":"Melatonin, a natural programmed cell death inducer in cancer","volume":"19","author":"Guerrero","year":"2012","journal-title":"Curr. Med. Chem"},{"key":"ref_25","first-page":"2103","article-title":"A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies","volume":"20","author":"Lissoni","year":"2000","journal-title":"Anticancer Res"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-079X.2005.00270.x","article-title":"Melatonin provokes cell death in human B-lymphoma cells by mitochondrial-dependent apoptotic pathway activation","volume":"39","author":"Trubiani","year":"2005","journal-title":"J. Pineal Res"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/j.1600-079X.2009.00675.x","article-title":"Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells","volume":"46","author":"Bejarano","year":"2009","journal-title":"J. Pineal Res"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-079X.2012.01006.x","article-title":"Melatonin inhibits cell proliferation and induces caspase activation and apoptosis in human malignant lymphoid cell lines","volume":"53","author":"Lee","year":"2012","journal-title":"J. Pineal Res"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1023\/A:1006442017658","article-title":"Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells","volume":"61","author":"Kiefer","year":"2000","journal-title":"Breast Cancer Res. Treat"},{"key":"ref_30","first-page":"59","article-title":"Effect of melatonin and all-trans retinoic acid on the proliferation and induction of the apoptotic pathway in the culture of human breast cancer cell line MCF-7","volume":"53","author":"Anchim","year":"2002","journal-title":"Pol. J. Pathol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.steroids.2010.06.002","article-title":"Melatonin inhibits mitogenic cross-talk between retinoic acid-related orphan receptor alpha (RORalpha) and ERalpha in MCF-7 human breast cancer cells","volume":"75","author":"Dong","year":"2010","journal-title":"Steroids"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejphar.2012.02.011","article-title":"Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: Molecular basis for the anticancer effect of these molecules","volume":"681","author":"Margheri","year":"2012","journal-title":"Eur. J. Pharmacol"},{"key":"ref_33","first-page":"319","article-title":"Oncostatic activity of pineal neuroendocrine treatment with the pineal indoles melatonin and 5-methoxytryptamine in untreatable metastatic cancer patients progressing on melatonin alone","volume":"21","author":"Lissoni","year":"2000","journal-title":"Neuro Endocrinol. Lett"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1600-079X.2008.00608.x","article-title":"Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: Potential mechanisms and clinical significance","volume":"45","author":"Tam","year":"2008","journal-title":"J. Pineal Res"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3109\/10715762.2011.623700","article-title":"Intracellular redox state as determinant for melatonin antiproliferative vs. cytotoxic effects in cancer cells","volume":"45","author":"Rodriguez","year":"2011","journal-title":"Free Radic. Res"},{"key":"ref_36","first-page":"45","article-title":"Melatonin decreases cell proliferation and induces melanogenesis in human melanoma SK-MEL-1 cells","volume":"49","author":"Cabrera","year":"2010","journal-title":"J. Pineal Res"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-079X.2007.00548.x","article-title":"The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes","volume":"45","author":"Pizarro","year":"2008","journal-title":"J. Pineal Res"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/0008-5472.CAN-05-2354","article-title":"Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin","volume":"66","author":"Herrera","year":"2006","journal-title":"Cancer Res"},{"key":"ref_39","unstructured":"Di Bella, L (, January September). Melatonin: An Essential Factor for the Treatment and Recovery from Leukemia and Cancer. Bremen, Germany."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000226978","article-title":"Clinical result with the pineal hormone melatonin in advanced cancer resistant to standard antitumor therapies","volume":"48","author":"Lissoni","year":"1991","journal-title":"Oncology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000014545","article-title":"Prospects of the clinical utilization of melatonin","volume":"7","author":"Bubenik","year":"1998","journal-title":"Biol. Signals Recept"},{"key":"ref_42","first-page":"1","article-title":"The Di Bella Method (DBM)","volume":"31","year":"2010","journal-title":"Neuro. Endocrinol. Lett"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3835(99)00366-3","article-title":"Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells","volume":"151","year":"2000","journal-title":"Cancer Lett"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/S0959-8049(99)00159-8","article-title":"Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumor patients with poor clinical status","volume":"35","author":"Lissoni","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0024-3205(99)00262-3","article-title":"Melatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro","volume":"65","author":"Mediavilla","year":"1999","journal-title":"Life Sci"},{"key":"ref_46","first-page":"3615","article-title":"Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine incorporation into cell nuclei and enhance apoptosis in the transplantable murine colon 38 cancer","volume":"18","author":"Winczyk","year":"1998","journal-title":"Anticancer Res"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-079X.1997.tb00308.x","article-title":"Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene","volume":"22","author":"Mediavilla","year":"1997","journal-title":"J. Pineal Res"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1081\/CBI-100106083","article-title":"Circadian rhythms of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), cortisol, and melatonin in women with breast cancer","volume":"18","author":"Haus","year":"2001","journal-title":"Chronobiol. Int"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.freeradbiomed.2008.09.017","article-title":"ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVB-stressed U937 cells","volume":"46","author":"Luchetti","year":"2009","journal-title":"Free Radic Biol. Med"},{"key":"ref_50","first-page":"53","article-title":"Decreased levels of 13-hydroxyoctadecadienoic acid (13-HODE) dehydrogenase in neoplastic tissue of human colon biopsies","volume":"5","author":"Silverman","year":"1996","journal-title":"Cancer Epidemiol. Biomark. Prev"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10911-011-9222-4","article-title":"Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer","volume":"16","author":"Hill","year":"2011","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"ref_52","first-page":"45","article-title":"Anti-angiogenic activity of melatonin in advanced cancer patients","volume":"22","author":"Lissoni","year":"2001","journal-title":"Neuro Endocrinol. Lett"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00595-003-2621-3","article-title":"The effects of melatonin on angiogenesis and wound healing","volume":"33","author":"SoybIr","year":"2003","journal-title":"Surg. Today"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Alvarez-Garc\u00eda, V., Gonz\u00e1lez, A., Alonso-Gonz\u00e1lez, C., Mart\u00ednez-Campa, C., and Cos, S (2012). Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells. J. Pineal Res.","DOI":"10.1111\/jpi.12007"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-079X.2009.00742.x","article-title":"Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia","volume":"48","author":"Park","year":"2010","journal-title":"J. Pineal Res"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kim, K.J., Choi, J.S., Kang, I., Kim, K.W., Jeong, C.H., and Jeong, J.W. (2012). Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model. J. Pineal Res.","DOI":"10.1111\/j.1600-079X.2012.01030.x"},{"key":"ref_57","first-page":"39","article-title":"Potential anticarcinogenic action of melatonin and other antioxidants mediated by antioxidative mechanisms","volume":"23","author":"Karbownik","year":"2002","journal-title":"Neuro Endocrinol. Lett"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ijrobp.2004.02.006","article-title":"Melatonin as a radioprotective agent: A review","volume":"59","author":"Vijayalaxmi","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_59","first-page":"49","article-title":"Radical-scavenging activity of melatonin, either alone or in combination with vitamin E, ascorbate or 2-mercaptoethanol as co-antioxidants, using the induction period method","volume":"25","author":"Kadoma","year":"2011","journal-title":"In Vivo"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.1039\/c0cp02801k","article-title":"On the direct scavenging activity of melatonin towards hydroxyl and a series of peroxyl radicals","volume":"13","author":"Galano","year":"2011","journal-title":"Phys. Chem. Chem. Phys"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1095-6433(97)00456-X","article-title":"Potential protective effects of melatonin on bone marrow of rats exposed to cytotoxic drugs","volume":"119","author":"Anwar","year":"1998","journal-title":"Comp. Biochem. Physiol. A"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0024-3205(98)00442-1","article-title":"Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing TLX5 lymphoma","volume":"63","author":"Rapozzi","year":"1998","journal-title":"Life Sci"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0277-5379(87)90340-3","article-title":"The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels","volume":"23","author":"Lissoni","year":"1987","journal-title":"Eur. J. Cancer Clin. Oncol"},{"key":"ref_64","first-page":"171","article-title":"Ruolo dei sistema abenulo-epifisario nella regolazione del tasso-piastrinemico","volume":"45","author":"Rossi","year":"1969","journal-title":"Boll. Soc. It. Biol. Sper"},{"key":"ref_65","first-page":"26","article-title":"Azione mielotropa della melatonina (MLT)","volume":"52","author":"Rossi","year":"1976","journal-title":"Boll. Soc. It. Biol. Sper"},{"key":"ref_66","unstructured":"Gupta, D., Attanasio, A., and Reiter, R.J. (1988). The Pineal Gland and Cancer. Brain Research Promotion, Brain Research Promootion."},{"key":"ref_67","first-page":"44","article-title":"Effetti della melatonina sui megacariociti viventi di midollo di ratto","volume":"53","author":"Gualano","year":"1977","journal-title":"Boll. Soc. It. Biol. Sper"},{"key":"ref_68","first-page":"1","article-title":"The effects of melatonin in human platelets","volume":"43","author":"Cardinali","year":"1993","journal-title":"Acta Physiol. Pharmacol. Ther. Latinoam"},{"key":"ref_69","first-page":"157","article-title":"Formazione di complessi tra melatonina (mlt) e basi puriniche e pirimidiniche","volume":"52","author":"Bucciarelli","year":"1976","journal-title":"Boll. Soc. It. Biol. Sper"},{"key":"ref_70","unstructured":"Rossi, M.T., Di Bella, L., Scalera, G., and Gualano, L. (1980, January 28\u201330). Platelet Turnover as Influenced by Melatonin. Bremen, Germany."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Jeffrey, G.A., and Saenger, W (1991). Hydrogen Bonding in Biological Structures, Springer-Verlag.","DOI":"10.1007\/978-3-642-85135-3"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1096\/fj.03-0694fje","article-title":"Evidence of melatonin synthesis by human lymphocytes and its physiological significance: Possible role as intracrine, autocrine, and\/or paracrine substance","volume":"18","author":"Calvo","year":"2004","journal-title":"FASEB J"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0304-3835(92)90050-6","article-title":"The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system","volume":"64","author":"Hill","year":"1992","journal-title":"Cancer Lett"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1096\/fasebj.9.13.7557023","article-title":"High-affinity binding of melatonin by human circulating T lymphocytes (CD4+)","volume":"9","author":"Calvo","year":"1995","journal-title":"FASEB J"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.4049\/jimmunol.159.8.3774","article-title":"Signal transduction for melatonin in human lymphocytes: Involvement of a pertussis toxin-sensitive G protein","volume":"159","author":"Pozo","year":"1997","journal-title":"J. Immunol"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-5728(95)00135-2","article-title":"Selective effect of methoxyindoles on the lymphocyte proliferation and melatonin binding to activated human lymphoid cells","volume":"63","author":"Konakchieva","year":"1995","journal-title":"J. Neuroimmunol"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.159.2.574","article-title":"Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: A possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes","volume":"159","author":"Calvo","year":"1997","journal-title":"J. Immunol"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000069464","article-title":"Circadian secretions of IL-2, IL-12, IL-6 and IL-10 in relation to the light\/dark rhythm of the pineal hormone melatonin in healthy humans","volume":"16","author":"Lissoni","year":"1998","journal-title":"Nat. Immun"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/S0024-3205(99)00479-8","article-title":"Melatonin activates Th1 lymphocytes by increasing IL-12 production","volume":"65","author":"Pozo","year":"1999","journal-title":"Life Sci"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF01923944","article-title":"Calmodulin mediates melatonin cytoskeletal effects","volume":"49","year":"1993","journal-title":"Experientia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1600-079X.2004.00141.x","article-title":"Melatonin stimulates calmodulin phosphorylation by protein kinase C","volume":"37","author":"Meza","year":"2004","journal-title":"J. Pineal Res"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1568026023394443","article-title":"Chemical and physical properties and potential mechanisms: Melatonin as a broad spectrum antioxidant and free radical scavenger","volume":"2","author":"Tan","year":"2002","journal-title":"Curr. Top. Med. Chem"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.lfs.2003.08.046","article-title":"Expression of membrane and nuclear melatonin receptors in mouse peripheral organs","volume":"74","author":"Naji","year":"2004","journal-title":"Life Sci"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-079X.2009.00684.x","article-title":"Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells","volume":"47","author":"Girgert","year":"2009","journal-title":"J. Pineal Res"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1600-079X.1992.tb00045.x","article-title":"Synergistic action of melatonin and vasoactive intestinal peptide in stimulating cyclic AMP production in human lymphocytes","volume":"12","author":"Calvo","year":"1992","journal-title":"J. Pineal Res"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-079X.1992.tb00055.x","article-title":"Binding sites for [3H]-melatonin in human platelets","volume":"13","author":"Vacas","year":"1992","journal-title":"J. Pineal Res"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-079X.1995.tb00149.x","article-title":"Immunomodulatory role of melatonin: Specific binding sites in human and rodent lymphoid cells","volume":"18","author":"Calvo","year":"1995","journal-title":"J. Pineal Res"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/0092-8674(95)90200-7","article-title":"The RXR heterodimers and orphan receptors","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/nar\/23.3.327","article-title":"Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification od CGP 52608 as a synthetic ligand","volume":"23","author":"Wiesenberg","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/378681a0","article-title":"Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid","volume":"378","author":"Renaud","year":"1995","journal-title":"Nature"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7588","DOI":"10.1016\/S0021-9258(20)89488-5","article-title":"Vitamin D receptor expression in human lymphocytes. Signal requirements and characterization by western blots and DNA sequencing","volume":"266","author":"Yu","year":"1991","journal-title":"J. Biol. Chem"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2174\/156802606777864890","article-title":"Vitamin D receptor agonists, cancer and the immune system: An intricate relationship","volume":"6","author":"Adorini","year":"2006","journal-title":"Curr. Top. Med. Chem"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0197-0186(94)90100-7","article-title":"Melatonin receptors: Localization, molecular pharmacology and physiological significance","volume":"24","author":"Morgan","year":"1994","journal-title":"Neurochem. Int"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0169-328X(96)00017-4","article-title":"The melatonin receptor in the human brain: cloning experiments and distribution studies","volume":"39","author":"Mazzucchelli","year":"1996","journal-title":"Brain Res. Mol. Brain Res"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00001756-199612200-00022","article-title":"The Mel1a melatonin receptor gene is expressed in human suprachiasmatic nuclei","volume":"8","author":"Weaver","year":"1996","journal-title":"Neuroreport"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1097\/00001756-199812210-00011","article-title":"Melatonin receptor subtype expression in human cerebellum","volume":"9","author":"Herman","year":"1998","journal-title":"Neuroreport"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1385\/ENDO:27:2:101","article-title":"Functional MT1 and MT2 melatonin receptors in mammals","volume":"27","author":"Dubocovich","year":"2005","journal-title":"Endocrine"},{"key":"ref_98","first-page":"1","article-title":"Orientamenti fisiologici nella terapia delle emopatie","volume":"145","year":"1974","journal-title":"Bull. Sc. Med"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0079-6123(08)62954-4","article-title":"Perspectives in pineal function","volume":"52","author":"Rossi","year":"1979","journal-title":"Prog. Brain Res"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-079X.1993.tb00501.x","article-title":"Inhibitory effect of melatonin on platelet activation induced by collagen and arachidonic acid","volume":"14","author":"Kornblihtt","year":"1993","journal-title":"J. Pineal Res"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-5728(98)00268-9","article-title":"Characterization of membrane melatonin receptor in mouse peritoneal macrophages: Inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein","volume":"95","author":"Guerriero","year":"1999","journal-title":"J. Neuroimmunol"},{"key":"ref_102","first-page":"BR527","article-title":"Melatonin effects on megakaryocyte membrane patch-clamp outward K+ current","volume":"8","author":"Bruschi","year":"2002","journal-title":"Med. Sci. Monit."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1210\/me.2003-0047","article-title":"Melatonin receptor signaling in pregnant and nonpregnant rat uterine myocytes as probed by large conductance Ca2+-activated K+ channel activity","volume":"17","author":"Steffens","year":"2003","journal-title":"Mol. Endocrinol"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-079X.2004.00123.x","article-title":"Melatonin inhibits outward delayed rectifier potassium currents in hippocampal CA1 pyramidal neuron via intracellular indole-related domains","volume":"36","author":"Hou","year":"2004","journal-title":"J. Pineal Res"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2006.03.033","article-title":"Role of protein kinase C-alpha inmelatonin signal transduction","volume":"252","author":"Sampson","year":"2006","journal-title":"Mol. Cell. Endocrinol"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1600-079X.2007.00468.x","article-title":"Involvement of protein kinase C in melatonin\u2019s oncostatic effect in C6 glioma cells","volume":"43","author":"Herrera","year":"2007","journal-title":"J. Pineal Res"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jsbmb.2008.02.009","article-title":"Melatonin prevents glucocorticoid inhibition of cell proliferation and toxicity in hippocampal cells by reducing glucocorticoid receptor nuclear translocation","volume":"110","author":"Quiros","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pros.20155","article-title":"Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism","volume":"63","author":"Sainz","year":"2005","journal-title":"Prostate"},{"key":"ref_109","first-page":"15","article-title":"Clinical pathology of the APUD system (apudopathy)","volume":"56","author":"Kvetnoi","year":"1978","journal-title":"Klin. Med. (Mosk)"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1177\/27.10.512327","article-title":"The diffuse neuroendocrine system. Studies of this newly discovered controlling system in health","volume":"27","author":"Polak","year":"1979","journal-title":"J. Histochem. Cytochem"},{"key":"ref_111","first-page":"74","article-title":"APUD system and neuroendocrine tumors (\u201capudomas\u201d)","volume":"39","author":"Raikhlin","year":"1997","journal-title":"Arkh. Patol"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00197547","article-title":"Carcinomas of the breast with endocrine differentiation: A review","volume":"425","author":"Maluf","year":"1994","journal-title":"Virchows Arch"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0046-8177(95)90033-0","article-title":"Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmiotic cells","volume":"26","author":"Bonkhoff","year":"1995","journal-title":"Hum. Pathol"},{"key":"ref_114","first-page":"1","article-title":"The APUD system (diffuse endocrine system) in normal and patological states","volume":"8","author":"Raikhlin","year":"1994","journal-title":"Physiol. Gen. Biol. Rev"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3181\/00379727-194-43063","article-title":"Influence of melatonin on mammary gland growth: in vivo and in vitro studies","volume":"194","author":"Mediavilla","year":"1990","journal-title":"Proc. Soc. Exp. Biol. Med"},{"key":"ref_116","first-page":"557","article-title":"Melatonin in human breast cancer tissue: Association with nuclear grade and estrogen receptor status","volume":"75","author":"Maestroni","year":"1996","journal-title":"Lab. Invest"},{"key":"ref_117","first-page":"453","article-title":"Diurnal variation in melatonin effect on adenosine triphosphate and serotonin release by human platelets","volume":"123","author":"Martinuzzo","year":"1990","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/S0024-3205(97)00234-8","article-title":"Evidence for tryptophan hydroxylase and hydroxy-indol-O-methyl-transferase mRNAs in human blood platelets","volume":"60","author":"Champier","year":"1997","journal-title":"Life Sci"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1152\/jappl.1955.7.4.425","article-title":"Quantity, assay and release of serotonin in human platelets","volume":"7","author":"Zucker","year":"1955","journal-title":"J. Appl. Physiol"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF02145892","article-title":"Enzymic formation of serotonin in mammalian blood platelets and red cells","volume":"27","author":"Marmaras","year":"1971","journal-title":"Experientia"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/0024-3205(93)90261-Z","article-title":"Melatonin effect on serotonin uptake and release in rat platelets: Diurnal variation in responsiveness","volume":"53","author":"Atienza","year":"1993","journal-title":"Life Sci"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1093\/carcin\/16.12.2945","article-title":"A 50 Hz magnetic field blocks melatonin-induced enhancement of junctional transfer in normal C3H\/10T1\/2 cells","volume":"16","author":"Ubeda","year":"1995","journal-title":"Carcinogenesis"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1247\/csf.22.347","article-title":"Effects of melatonin on proliferation, oxidative stress and Cx32 gap junction protein expression in primary cultures of adult rat hepatocytes","volume":"22","author":"Kojima","year":"1997","journal-title":"Cell Struct. Funct"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1034\/j.1600-079X.2000.290306.x","article-title":"Melatonin effects on intercellular junctional communication in MCF-7 human breast cancer cells","volume":"29","author":"Cos","year":"2000","journal-title":"J. Pineal Res"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF02527721","article-title":"Effect of melatonin on beta-tubulin and MAP2 expression in NIE-115 cells","volume":"21","author":"Maldonado","year":"1996","journal-title":"Neurochem. Res"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-4886(03)00085-2","article-title":"Melatonin prevents cytoskeletalalterations and oxidative stress induced by okadaic acid in N1E-115 cells","volume":"182","author":"Bellon","year":"2003","journal-title":"Exp. Neurol"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","article-title":"Melatonin in the treatment of cancer: A systematic review of randomized controlled trials and meta-analysis","volume":"39","author":"Mills","year":"2005","journal-title":"J. Pineal Res"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.patbio.2006.12.025","article-title":"Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms","volume":"55","author":"Lissoni","year":"2007","journal-title":"Pathol. Biol. (Paris)"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2174\/092986710791233689","article-title":"Clinical uses of melatonin: Evaluation of human trials","volume":"17","author":"Mediavilla","year":"2010","journal-title":"Curr. Med. Chem"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1534735411425484","article-title":"Melatonin as adjuvant cancer care with and without chemotherapy: A systematic review and meta-analysis of randomized trials","volume":"11","author":"Seely","year":"2012","journal-title":"Integr. Cancer Ther"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00280-012-1828-8","article-title":"The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: A meta-analysis of randomized controlled trials","volume":"69","author":"Wang","year":"2012","journal-title":"Cancer Chemother. Pharmacol"},{"key":"ref_132","first-page":"119","article-title":"Anticancer neuroimmunomodulation by pineal hormones other than melatonin: Preliminary phase II study of the pineal indole 5-methoxytryptophol in association with low-dose IL-2 and melatonin","volume":"11","author":"Lissoni","year":"1997","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1200\/JCO.2002.11.004","article-title":"Melatonin: From basic research to cancer treatment clinics","volume":"20","author":"Vijayalaxmi","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_134","first-page":"30","article-title":"Melatonin in clinical oncology","volume":"23","author":"Bartsch","year":"2002","journal-title":"Neuro Endocrinol. Lett"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"9789","DOI":"10.1158\/0008-5472.CAN-06-1776","article-title":"Melatonin in cancer management: Progress and promise","volume":"66","author":"Jung","year":"2006","journal-title":"Cancer Res"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/S1462399409000982","article-title":"Melatonin and breast cancer: Cellular mechanisms, clinical studies and future perspectives","volume":"11","author":"Grant","year":"2009","journal-title":"Expert Rev. Mol. Med"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10552-012-9927-8","article-title":"A randomized controlled trial of oral melatonin supplementation and breast cancer biomarkers","volume":"23","author":"Schernhammer","year":"2012","journal-title":"Cancer Causes Control"},{"key":"ref_138","unstructured":"Di Bella, L (September, January Japan,). Physiological basis for a rational therapy of bone marrow diseases. Kyoto."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.2174\/092986710794183015","article-title":"Basic mechanisms involved in the anti-cancer effects of melatonin","volume":"17","author":"Mediavilla","year":"2010","journal-title":"Curr. Med. Chem"},{"key":"ref_140","first-page":"373","article-title":"Cytochalasin B influence on megakaryocyte patch-clamp","volume":"460","author":"Gualano","year":"1999","journal-title":"Adv. Exp. Med. Biol"},{"key":"ref_141","first-page":"581","article-title":"Involvement of a p53-independent and post-ttranscriptional up-regulation for p21WAF\/CIP1 following destabilization of the actin cytoskeleton","volume":"34","author":"Lee","year":"2009","journal-title":"Int. J. Oncol"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0021-9258(18)91329-3","article-title":"Purification and properties of a microsomal enzyme system catalyzing the reactivation of reduced ribonuclease and lysozyme","volume":"239","author":"Goldberger","year":"1964","journal-title":"J. Biol. Chem"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3233(08)60420-9","article-title":"Protein structure in relation to function and biosynthesis","volume":"11","author":"Anfinsen","year":"1956","journal-title":"Adv. Protein Chem"},{"key":"ref_144","first-page":"184","article-title":"The tertiary structure of ribonuclease","volume":"15","author":"Anfinsen","year":"1962","journal-title":"Brookhaven Symp. Biol"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"R352","DOI":"10.1016\/S0960-9822(99)80223-1","article-title":"Chaperonins","volume":"9","author":"Ellis","year":"1999","journal-title":"Curr. Biol"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"R881","DOI":"10.1016\/j.cub.2003.10.051","article-title":"Protein folding: importance of the Anfinsen cage","volume":"13","author":"Ellis","year":"2003","journal-title":"Curr. Biol"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/01.ede.0000253934.58618.98","article-title":"Residential magnetic fields, medication use, and the risk of breast cancer","volume":"18","author":"Davis","year":"2007","journal-title":"Epidemiology"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1158\/1055-9965.EPI-11-1128","article-title":"Night shift work and hormone levels in women","volume":"21","author":"Davis","year":"2012","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"key":"ref_149","first-page":"857","article-title":"Complete objective response to biological therapy of plurifocal breast carcinoma","volume":"29","year":"2008","journal-title":"Neuro. Endocrinol. Lett"},{"key":"ref_150","first-page":"751","article-title":"The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer","volume":"32","year":"2011","journal-title":"Neuro Endocrinol. Lett"},{"key":"ref_151","first-page":"249","article-title":"The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 23 tumors of the head and neck","volume":"33","author":"Biagio","year":"2012","journal-title":"Neuro Endocrinol Lett"},{"key":"ref_152","unstructured":"Di Bella, L (January, January Italy,). Reggio Calabria."},{"key":"ref_153","unstructured":"Di Bella, L (1997). Cancro: Siamo Sulla Strada Giusta?, Travel Factory."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/bmj.320.7239.895","article-title":"How many deaths have been avoided through improvements in cancer survival?","volume":"320","author":"Richards","year":"2000","journal-title":"BMJ"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clon.2004.06.007","article-title":"The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies","volume":"16","author":"Morgan","year":"2004","journal-title":"Clin. Oncol"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/bjc.1998.379","article-title":"Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin\u2019s lymphoma (B-NHL)\u2014Results of the UKCCSG 9003 protocol","volume":"77","author":"Atra","year":"1998","journal-title":"Br. J. Cancer"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/annonc\/mdp529","article-title":"Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: A prospective multicentric phase II study of the Groupe d\u2019Etude des Lymphomes de l\u2019Adulte (GELA)","volume":"21","author":"Ferlay","year":"2010","journal-title":"Ann. Oncol"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm.2890","article-title":"Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B","volume":"18","author":"Sun","year":"2012","journal-title":"Nat. Med"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/stem.1058","article-title":"Radiation-induced reprogramming of breast cancer cells","volume":"30","author":"Lagadec","year":"2012","journal-title":"Stem Cells"},{"key":"ref_160","first-page":"50","article-title":"Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status","volume":"22","author":"Norsa","year":"2007","journal-title":"Cancer Biother. Radiopharm"},{"key":"ref_161","first-page":"68","article-title":"Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status","volume":"21","author":"Norsa","year":"2006","journal-title":"Cancer Biother. Radiopharm"},{"key":"ref_162","first-page":"353","article-title":"Chronic lymphocytic leukemia: Long-lasting remission with combination of cyclophosphamide, somatostatin, bromocriptine, retinoids, melatonin, and ACTH","volume":"24","author":"Todisco","year":"2009","journal-title":"Cancer Biother. Radiopharm"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.mjt.0000209675.83958.9c","article-title":"Low-grade non-Hodgkin lymphoma at advanced stage: a case successfully treated with cyclophosphamide plus somatostatin, bromocriptine, retinoids, and melatonin","volume":"14","author":"Todisco","year":"2007","journal-title":"Am. J. Ther"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/01.mjt.0000179626.18283.64","article-title":"Relapse of high-grade non-Hodgkin\u2019s lymphoma after autologous stem cell transplantation: A case successfully treated with cyclophosphamide plus somatostatin, bromocriptine, melatonin, retinoids, and ACTH","volume":"13","author":"Todisco","year":"2006","journal-title":"Am. J. Ther"},{"key":"ref_165","first-page":"171","article-title":"Cyclophosphamide plus somatostatin, bromocriptin, retinoids, melatonin and ACTH in the treatment of low-grade non-Hodgkin\u2019s lymphomas at advanced stage: Results of a phase II trial","volume":"16","author":"Todisco","year":"2001","journal-title":"Cancer Biother. Radiopharm"},{"key":"ref_166","unstructured":"Di Bella, G (2005). Il Metodo Di Bella, Mattioli."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/2\/2410\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:44:30Z","timestamp":1760219070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/2\/2410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":166,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2]]}},"alternative-id":["ijms14022410"],"URL":"https:\/\/doi.org\/10.3390\/ijms14022410","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}